相关实验视频

Updated: May 16, 2025

Modeling Chemotherapy Resistant Leukemia In Vitro

Modeling Chemotherapy Resistant Leukemia In Vitro

Published on: February 9, 2016

瘤化疗耐药性中的NLRs:双刃剑

Lili Sun¹, Yanmei Zhu², Yuan Yuan³

¹Department of Pathology, Cancer Hospital of China Medical University (Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital & Institute), Shenyang, 110042, China; Tumor Etiology and Screening Department of Cancer Institute and General Surgery, The First Hospital of China Medical University, Shenyang, 110001, China; Key Laboratory of Cancer Etiology and Prevention in Liaoning Education Department, The First Hospital of China Medical University, Shenyang, 110001, China; Key Laboratory of GI Cancer Etiology and Prevention in Liaoning Province, The First Hospital of China Medical University, Shenyang, 110001, China.

Chemico-biological interactions

|April 3, 2025

概括

核酸结合寡聚化域 (NOD) 类受体 (NLR) 在癌症中充当双刃剑,影响瘤生长和化疗耐药性. 了解NLRs为改善癌症治疗疗效提供了一个有希望的治疗目标.

科学领域:

免疫学免疫学免疫学
分子生物学分子生物学
在瘤学瘤学.

背景情况:

核酸结合寡聚化域 (NOD) 类受体 (NLR) 是细胞质蛋白质,对先天免疫和适应性免疫激活至关重要.
NLRs调节主要基因相容性复合体 (MHC) 类I和II基因,并参与炎症体信号通路.
在瘤进展,转移和瘤微环境 (TME) 中NLRs的双重作用是研究的一个重要领域.

研究的目的:

系统地审查NLR家族对各种恶性瘤化学敏感性的影响.
阐明NLR在癌症中的上游和下游信号通路的调节机制.
探索NLRs作为克服化疗耐药性的双向治疗目标的应用价值.

主要方法:

系统性文献审查,重点关注NLR和癌症化学敏感性.
对NLRs在TME内的瘤发育,入侵和转移中的作用的分析.
在化疗耐药性背景下,研究NLRs调节的信号通路.

主要成果:

NLRs表现出"双刃剑"效应,可能促进或抑制瘤生长和化疗耐药性.
NLRs显著影响各种化疗治疗的疗效.
特定的NLR及其相关途径可以被准以调节化学敏感性.

结论:

在恶性瘤中,NLRs是一个有希望的,但复杂的,双向的治疗标.
针对NLRs提供了一种潜在的策略,以提高化疗疗效和克服耐药性.
进一步研究NLRs的确切作用和监管机制对于临床应用至关重要.

关键词:

化学疗法耐药性抗化学疗法耐药性双重角色 (无论是积极的还是消极的角色)恶性瘤是一种恶性瘤.在NLRP3中,NLRP3是NLRP3中的一个.对于NLRs来说,它们是非常重要的.在NOD1/2中.

更多相关视频

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

相关概念视频

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Cancer Stem Cells and Tumor Maintenance

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...